Solos Endoscopy, Inc. Enters Multi-Billion Dollar Veterinary Market with Launch of Revamped Endoscopic Veterinary Product Line
BOSTON, June 30, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce the launch of its revamped Veterinary Product Line of endoscopic equipment, scopes and instruments. The Solos Veterinary Product Line consists of more than 48 SKUs with prices ranging from $75 to $3900.
According to the American Pet Product Association, in 2009, Consumers spent more than $45 Billion on their pets, with more than $12 Billion spent on Vet Care.
"Our Veterinary Product Line is going to open tremendous doors for us as a Company. We believe that we can enter this market with minimal cost and maximize our bottom line by offering great products at an affordable cost," stated Bob Segersten, President of Solos Endoscopy, Inc.
Veterinary endoscopy is a minimally invasive technique for performing procedures through natural openings in the body or through one or more tiny holes rather than through large incisions. Endoscopic procedures such as Laparoscopic Spays, Gastropexy and Otoscopy, allow veterinarians to offer their patients less pain, minimal recovery time and fewer complications. In many cases, performing an endoscopic procedure versus a traditional open surgical procedure allows for it to be done as an outpatient procedure, which is a less painful and traumatic alternative for both patient and owner.
In further news, the Company is set to launch their newly designed and interactive website, www.solosendoscopy.com on Friday July 1, 2011. The online venue serves as a "virtual catalog" for existing and new customers and includes comprehensive information for shareholders, investors and potential partners alike. The updated look showcases streamlined navigation to allow for easy-to-use functionality, allowing users to quickly reference desired information making it easier for Hospitals, Clinics, Healthcare Centers, Medical Centers and Surgery Centers across the United States to identify and select from Solos' vast product line.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
Share this article